ZIOPHARM (ZIOP) Reports Q3 Loss Doubles
Tweet Send to a FriendGet Alerts ZIOP Hot Sheet
Price: $1.95 +0.52%
Revenue Growth %: 0.0%
Financial Fact:
Other income, net: -4K
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: 0.0%
Financial Fact:
Other income, net: -4K
Today's EPS Names:
ATU, CRWS, CLC, More
Trade ZIOP Now!
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) reports Q3 loss of $0.26, versus ($0.13) reported for the same period a year ago.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
- Adobe Systems, Inc. (ADBE) Tops Q2 EPS by 2c; Issues Q3 Outlook
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
